These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10694291)

  • 21. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
    Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
    J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia.
    Birnbaum J; Hein OV; Lührs C; Rückbeil O; Spies C; Ziemer S; Gründling M; Usichenko T; Meissner K; Pavlovic D; Kox WJ; Lehmann C
    Crit Care; 2006 Feb; 10(1):R29. PubMed ID: 16507148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of severe multiple trauma complicated by acute lung injury on endothelial cell activity].
    Siemiatkowski A; Kłoczko J; Wereszczyńska-Siemiatkowska U; Czaban SL
    Przegl Lek; 2001; 58(7-8):767-71. PubMed ID: 11769384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma D-dimer concentration in patients with systemic sclerosis.
    Marie I; Borg JY; Hellot MF; Levesque H
    Br J Dermatol; 2008 Feb; 158(2):392-5. PubMed ID: 18028493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
    Thivolet J; Perrot H; Meunier F; Bouchet B
    Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients.
    Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A
    Mediators Inflamm; 2005 Aug; 2005(3):144-9. PubMed ID: 16106100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen V and vascular injury promote lung architectural changes in systemic sclerosis.
    Parra ER; Aguiar AC; Teodoro WR; de Souza R; Yoshinari NH; Capelozzi VL
    Clin Respir J; 2009 Jul; 3(3):135-42. PubMed ID: 20298396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis.
    Mok MY; Cheung BM; Lo Y; Leung RY; Wong WS; Lau CS
    J Rheumatol; 2007 Nov; 34(11):2224-9. PubMed ID: 17937467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favorable effects of plasma factor XIII on lower esophageal sphincter pressure of progressive systemic sclerosis.
    Maekawa Y; Nogita T; Yamada M
    Arch Dermatol; 1987 Nov; 123(11):1440-1. PubMed ID: 3674907
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?
    Matucci-Cerinic M; Pignone A; Lotti T; Spillantini G; Curradi C; Leoncini G; Iannone F; Falcini F; Cagnoni M
    J Rheumatol; 1990 Mar; 17(3):328-30. PubMed ID: 2159071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.